Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

EGFR

Items 51-60 of 69

Page
per page
  1. CUDC-101
    A4092 CUDC-101
     1 Citation
    Target: Histone Deacetylases (HDACs)|EGFR|ErbB
    Summary: Multitargeted HDAC inhibitor
      ≥21.7 mg/mL
  2. Lapatinib Ditosylate
    A3967 Lapatinib Ditosylate
    Target: EGFR|ErbB-2
    Summary: EGFR/HER2 inhibitor,potent and selective
      ≥24.3 mg/mL
  3. Ixabepilone
    A3513 Ixabepilone
    Summary: Epothilone B analog;microtubule-stabilizing agent
      ≥22.25 mg/mL
  4. Icotinib Hydrochloride
    A3482 Icotinib Hydrochloride
    Summary: EGFR inhibitor,potent and specific
      Soluble in DMSO
  5. Gefitinib hydrochloride
    A3433 Gefitinib hydrochloride
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; ≥4.28 mg/mL
  6. Erlotinib
    A3397 Erlotinib
     6 Citation
    Summary: EGFR tyrosine kinase inhibitor
      insoluble in H2O; ≥19.65 mg/mL
  7. CO-1686 (AVL-301)
    A3320 CO-1686 (AVL-301)
     1 Citation
    Target: EGFR
    Summary: EGFR inhibitor
      ≥27.8 mg/mL
  8. BMS-690514
    A3256 BMS-690514
    Summary: HER/EGFR inhibitor
      Soluble in DMSO
  9. BIBX 1382
    A3240 BIBX 1382
    Summary: EGFR inhibitor,potent and selective
      Soluble in DMSO
  10. AC480 (BMS-599626)
    A2822 AC480 (BMS-599626)
    Target: EGFR
    Summary: HER1/2 inhibitor,selective and efficacious
      ≥28.35 mg/mL

Items 51-60 of 69

Page
per page